Nuclera closes $75 million USD financing

Nuclera, the biotechnology company accelerating protein expression and purification workflows through its benchtop protein system, today announced it has completed a USD $75 million financing round (circa £57 million).

Colon cancer screening kits have a high rate of untestable samples

More than a tenth of fecal immunochemical tests, used for routine colorectal cancer screening, contained samples that could not be processed by labs, according to

November 16, 2023

Breakthrough blood test improves early diagnosis of pancreatic cancer

An experimental blood test detects early-stage pancreatic cancer more effectively than other available tests, reports a new study published in Cancer Letters.

October 4, 2024

ONL Therapeutics seeks upto $100m to further eye disease pipeline – Pharmaceutical Technology

Adult woman having a visit at female opthalmologist’s office. Credit: macniak via Getty Images Ophthalmological disease company ONL Therapeutics is currently seeking investor capital or

November 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.